GSK, RSV and Shingles
GSK's RSV, Shingles vaccines show on-par immune response in joint trial
(Reuters) -British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot together generated the same immune response in a late-stage trial as separate adminstration of the vaccines.
GSK makes Brooke Shields the star of shingles vaccination push
GSK has turned to Brooke Shields to get the message out about shingles vaccination. | GSK has turned to Brooke Shields to get the message out about shingles vaccination. The drugmaker has worked with the model and actor to talk to female celebrities and patients aged 50 years and up about the power that comes from aging and how shingles threatens their health.
GSK Builds Combo Case for RSV, Shingles Shots With Phase III Data
If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients and potentially bolster GSK’s faltering sales for both vaccines.
GSK's RSV vaccine meets main goal when co-administered with shingles shot
British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with its shingles shot, met the main goal of a late-stage trial in adults over 50 years of age.
GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults
GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The study showed a non-inferior immune response and good safety profiles. The results will support regulatory submissions to the FDA and EMA.
GSK Reports Positive Data From Co-administration Of RSV And Shingles Vaccines
GSK plc (GSK, GSK.L) announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the
GSK Sees Positive Results in Trial of Combination RSV, Shingles Vaccine
GSK recorded positive topline data in a late stage trial of its respiratory syncytial virus vaccine combined with a shingles vaccine in treating adults 50 years and older. The British pharma giant said Wednesday a Phase 3 study evaluating RSV vaccine Arexvy co-administered with Shingrix met the primary endpoint,
GSK posts late-stage trial win for co-administered RSV and shingles vaccines
GSK (NYSE:GSK) announced Wednesday that its Arexvy vaccine for respiratory syncytial virus (RSV) and its Shingrix vaccine for shingles reached the main goal in a Phase 3 trial when they were co-administered in adults aged 50 and older.
thehealthy2d
Brooke Shields’ Newest Campaign for Women: “There Is Power in Asking”
Shields has been vocal about women's wellness and now backs an initiative for women to be aware of an infection that's ...
Doctor explains ‘painful’ first symptoms of shingles after Demi Moore’s health struggle
Demi Moore made a shock move into horror with new movie The Substance but as well as losing 20 pounds for the role, the ...
knowyourmeme5d
Shingles Doesn't Care
Shingles Doesn't Care is a catchphrase that comes from part of a 30-second TV commercial for SHINGRIX, which is a vaccine for ...
More Australians now eligible for free shingles vaccine as government expands program
More than 200,000 Australians will now be eligible for a free shingles vaccinations, as the government expands their immunisation program.
Brooke Shields talks shingles and THRIVE@50+ campaign
Actress Brooke Shields talks about the THRIVE@50+ campaign to spread the word about the risks of shingles and important ...
MarketWatch8d
Solar Panels vs. Solar Shingles (2024)
Leonardo David is a writer and energy consultant who has worked on projects funded by the Inter-American Development Bank. An electromechanical engineer, he has written about solar energy and the ...
Forbes4d
9 Types Of Roofing You Should Consider
Most homeowners in the U.S. choose asphalt shingles because they are of the easiest to find, most affordable and versatile types of roofing. The most durable types of roofing are slate and clay ...
Immunocompromised to receive free shingles vaccine
More than 200,000 Australians who are immunocompromised will gain free access to the shingles vaccine in an expansion of a ...